HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients SANTA CLARA, Calif. --(...
Vortioxetine clinical phase III data show significant improvement in symptoms of major depression Takeda and Lundbeck present results from pivotal...
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare...
Rise and shine, everyone. Another day awaits. And a busy one is predicted. We will be attending a lengthy meeting ourselves, in fact. While you ponder your own schedules and what-not, here are a few items to help you get started. Hope the day is pleasant and productive....
SEC Probes Drug Mergers For Insider Trading (Wall Street Journal)
AstraZeneca Explores Alliances With Competitors (Bloomberg News)
Roche Invests Another $71M In China (China Post)
1 Comment
Wow Ed, your up early. Bright eyed and bushy tailed I see..